128 related articles for article (PubMed ID: 8534004)
1. Whither interferon for myeloma and other hematologic malignancies?
Alexanian R; Weber D
Ann Intern Med; 1996 Jan; 124(2):264-5. PubMed ID: 8534004
[No Abstract] [Full Text] [Related]
2. Alpha-2b recombinant interferon (Intron-A) as maintenance treatment in multiple myeloma.
Avvisati G; Petrucci MT; Pulsoni A; Tribalto M; Lauta VM; Gernone A; Boccadoro M; Marmont F; Pileri A; Dammacco F
Eur J Haematol Suppl; 1990; 52():9-11. PubMed ID: 2279547
[No Abstract] [Full Text] [Related]
3. Interferons in the management of multiple myeloma.
Cooper MR
Semin Oncol; 1988 Oct; 15(5 Suppl 5):21-5. PubMed ID: 3057642
[No Abstract] [Full Text] [Related]
4. Rapid response to recombinant interferon alpha 2B and high-dose prednisone in multiple drug-resistant multiple myeloma.
Wahlin A; Holm J
Eur J Haematol; 1989 Oct; 43(4):352-4. PubMed ID: 2583262
[No Abstract] [Full Text] [Related]
5. Maintenance treatment of multiple myeloma with alpha interferon versus an alternating schedule of alpha interferon and chemotherapy. Greek Myeloma Study Group (GMSG).
Maniatis A
Eur J Cancer; 1991; 27 Suppl 4():S49-50. PubMed ID: 1799479
[No Abstract] [Full Text] [Related]
6. Multiple myeloma: intensified maintenance therapy with recombinant interferon-alpha-2b plus glucocorticoids.
Palumbo A; Boccadoro M; Garino LA; Gallone G; Frieri R; Pileri A
Eur J Haematol; 1992 Aug; 49(2):93-7. PubMed ID: 1397246
[TBL] [Abstract][Full Text] [Related]
7. [Interferon therapy in multiple myeloma].
Ludwig H; Scheithauer W; Kührer I; Kuzmits R; Gisslinger G; Linkesch W; Zielinski C; Fritz E
Onkologie; 1988 Aug; 11(4):192-6. PubMed ID: 3054670
[TBL] [Abstract][Full Text] [Related]
8. Oral hairy leukoplakia in a patient with multiple myeloma.
Blomgren J; Bäck H
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 1996 Oct; 82(4):408-10. PubMed ID: 8899778
[TBL] [Abstract][Full Text] [Related]
9. Complete remission induction with combined VBMCP chemotherapy and interferon (rIFN alpha 2b) in patients with multiple myeloma.
Oken MM; Kyle RA; Greipp PR; Kay NE; Tsiatis A; Gregory SA; Spiegel R J; O'Connell M J
Leuk Lymphoma; 1996 Feb; 20(5-6):447-52. PubMed ID: 8833401
[TBL] [Abstract][Full Text] [Related]
10. Interferon and multiple myeloma.
Lauta VM
Med Oncol; 1995 Mar; 12(1):63-9. PubMed ID: 8542250
[TBL] [Abstract][Full Text] [Related]
11. Consolidation treatment with dexamethasone and alpha-2B recombinant interferon further reduces the M-component level in multiple myeloma patients responding to conventional induction chemotherapy.
Palumbo AP; Garino AL; Frieri R; Gallone G; Boccadoro M; Pileri A
Haematologica; 1990; 75(6):576-8. PubMed ID: 2098302
[TBL] [Abstract][Full Text] [Related]
12. Experience with poorly myelosuppressive chemotherapy schedules for advanced myeloma. The Cooperative Group of Study and Treatment of Multiple Myeloma.
Brugnatelli S; Riccardi A; Ucci G; Mora O; Barbarano L; Piva N; Piccinini L; Bergonzi C; De Paoli A; Di Stasi M; Rinaldi E; Trotti G; Petrini M; Ascari E
Br J Cancer; 1996 Mar; 73(6):794-7. PubMed ID: 8611382
[TBL] [Abstract][Full Text] [Related]
13. A randomised trial of cyclophosphamide with and without low dose alpha-interferon in the treatment of newly diagnosed myeloma.
Aitchison R; Williams A; Schey S; Newland AC
Leuk Lymphoma; 1993 Feb; 9(3):243-6. PubMed ID: 8471984
[TBL] [Abstract][Full Text] [Related]
14. Therapy of multiple myeloma. Italian Multiple Myeloma Study Group.
Boccadoro M; Avvisati G; Cantonetti M; Cavo-Comotti BM; Frieri R; Gallamini A; Gallone G; Lauta VM; Liberati M; Marmont F
Pathol Biol (Paris); 1990 Oct; 38(8):829. PubMed ID: 2274374
[No Abstract] [Full Text] [Related]
15. Acute and definitive renal failure in progressive multiple myeloma treated with recombinant interferon alpha-2a: report of two patients.
Noël C; Vrtovsnik F; Facon T; Noël-Walter MP; Hazzan M; Jouet JP; Bauters F; Lelièvre G
Am J Hematol; 1992 Dec; 41(4):298-9. PubMed ID: 1288297
[No Abstract] [Full Text] [Related]
16. Interferon-alpha 2b added to melphalan-prednisone for initial and maintenance therapy in multiple myeloma. A randomized, controlled trial. The Nordic Myeloma Study Group.
Ann Intern Med; 1996 Jan; 124(2):212-22. PubMed ID: 8533996
[TBL] [Abstract][Full Text] [Related]
17. [Results of alternating treatment of multiple myeloma--cytostatics VBMCP and recombinant interferon alfa-2B].
Gola A; Usnarska-Zubkiewicz L; Wołowiec D; Urbaniak-Kujda D; Kotlarek-Haus S
Pol Arch Med Wewn; 1993 Aug; 90(2):134-41. PubMed ID: 8247946
[TBL] [Abstract][Full Text] [Related]
18. Maintenance treatment with recombinant interferon alfa-2b in patients with multiple myeloma responding to conventional induction chemotherapy.
Mandelli F; Avvisati G; Amadori S; Boccadoro M; Gernone A; Lauta VM; Marmont F; Petrucci MT; Tribalto M; Vegna ML
N Engl J Med; 1990 May; 322(20):1430-4. PubMed ID: 2184356
[TBL] [Abstract][Full Text] [Related]
19. [Advances in the treatment of refractory multiple myeloma].
Lu SP
Zhonghua Nei Ke Za Zhi; 1990 Mar; 29(3):178-80. PubMed ID: 2209248
[No Abstract] [Full Text] [Related]
20. A case of malignant melanoma that developed multiple metastases after switching from interferon-beta to pegylated interferon-alpha-2b as adjuvant therapy.
Fukumoto T; Fujiwara S; Sakaguchi M; Oka M; Nishigori C
Eur J Dermatol; 2018 Feb; 28(1):115-116. PubMed ID: 29171409
[No Abstract] [Full Text] [Related]
[Next] [New Search]